Enanta Pharma loses appeal in Pfizer Paxlovid patent case
Go back to Enanta Pharma loses appeal in Pfizer Paxlovid patent case| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 12.70 -0.54 (4.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.24 | 52 Week High | $34.49 | |||
| Open | $13.09 | 52 Week Low | $20.39 | |||
| Day High | $13.21 | P/E | N/A | |||
| Day Low | $12.44 | EPS | $-3.18 | |||
| Volume | 312,791 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.65 -0.13 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.78 | 52 Week High | $37.39 | |||
| Open | $27.69 | 52 Week Low | $28.25 | |||
| Day High | $27.75 | P/E | 16.76 | |||
| Day Low | $27.40 | EPS | $1.65 | |||
| Volume | 27,633,347 | |||||
